How Long Does It Take to Get Breast Biopsy Results?

Waiting for breast biopsy results can be one of the most anxiety-provoking parts of the breast cancer journey.

You may have had an abnormal mammogram, ultrasound, or MRI. You completed the biopsy. And now you are waiting.

Every day can feel like a week.

Many patients understandably wonder: Why does it take so long?

The answer is that processing a breast biopsy is much more complicated than simply looking at a piece of tissue under a microscope. Before a pathologist can make a diagnosis, your biopsy specimen must go through multiple steps involving several different healthcare professionals. And if breast cancer is found, additional testing is often needed before your oncology team has the information necessary to begin discussing a treatment plan.

Depending on the laboratory, staffing, weekends, holidays, whether specialized testing is required, and whether samples need to be sent to another laboratory, the entire process can sometimes take several weeks.

Understanding what is happening behind the scenes may make the waiting a little easier.

What Happens to My Breast Biopsy After It Is Removed?

Once the radiologist or surgeon obtains the biopsy, the tissue begins a surprisingly labor-intensive journey through the pathology laboratory.

Multiple people may be involved before the final slides ever reach the pathologist.

While the exact process varies somewhat between laboratories, it generally includes several steps.

Step 1: The Specimen Is Collected and Identified

Immediately after the biopsy, the tissue is placed into a properly labeled specimen container.

The patient’s identifying information and the location of the biopsy must be carefully documented.

This may sound simple, but specimen identification is critically important. Pathology laboratories have strict procedures designed to ensure that every piece of tissue remains correctly matched to the right patient and biopsy location throughout processing.

Step 2: The Tissue Is Preserved

Most breast biopsy tissue is placed into a preservative called formalin.

This process, called fixation, preserves the tissue so that the cells maintain their structure and can later be evaluated under the microscope.

Proper fixation is also important because subsequent tests—including estrogen receptor, progesterone receptor, and HER2 testing—depend on appropriately handled tissue.

Step 3: The Specimen Is Examined and Prepared

The specimen is evaluated in the pathology laboratory and prepared for processing.

Depending on the type and amount of tissue, portions are selected to be placed into small containers called cassettes.

For larger surgical specimens, this step can be much more extensive because the tissue may need to be carefully measured, described, oriented, inked, and sampled.

Step 4: The Tissue Is Processed

The tissue then undergoes processing to remove water and prepare it to be embedded in paraffin wax.

This allows the tissue to become firm enough to be cut into extremely thin sections.

This processing itself takes time and is performed using specialized laboratory equipment.

Step 5: The Tissue Is Embedded in Paraffin

The processed tissue is placed into a block of paraffin wax.

You may sometimes hear your healthcare team refer to a “tissue block” or “paraffin block.”

This is what they mean.

The preserved tissue inside these blocks can also be used later for additional testing when necessary.

Step 6: Extremely Thin Slices Are Cut

A laboratory professional called a histotechnologist uses specialized equipment called a microtome to cut extremely thin sections from the tissue block.

These delicate sections are placed onto glass microscope slides.

Getting high-quality sections that can be accurately interpreted requires considerable technical skill.

Step 7: The Slides Are Stained

The tissue is then stained so that different parts of the cells can be seen under the microscope.

One of the standard stains is called hematoxylin and eosin, or H&E.

Without staining, many of the cellular structures that the pathologist needs to evaluate would be extremely difficult to distinguish.

Step 8: The Slides Finally Reach the Pathologist

Only after all of this preparation does the pathologist examine the tissue under the microscope.

The pathologist evaluates the architecture and appearance of the cells and determines what the tissue represents.

Sometimes the diagnosis is straightforward.

Other times, additional tissue levels, special stains, immunohistochemistry, or consultation with another pathologist may be necessary before the diagnosis can be finalized.

So when you are waiting for a pathology report, there may be an entire team working on your specimen even though you haven’t received a result yet.

How Long Does the Initial Breast Biopsy Result Take?

There isn’t one universal timeline.

Some breast biopsy results are available within several business days. Others take longer.

Laboratory volume, staffing, weekends, holidays, the complexity of the specimen, whether additional stains are needed, and whether another pathologist needs to review the case can all affect turnaround time.

At some institutions, particularly during periods of limited pathology staffing or around holidays, the process may take considerably longer.

The first pathology report may tell you whether cancer is present and, if so, provide an initial diagnosis such as:

Invasive ductal carcinoma
Invasive carcinoma of no special type
Invasive mammary carcinoma
Invasive lobular carcinoma
Ductal carcinoma in situ (DCIS)

But if breast cancer is found, this initial diagnosis is only part of the information your doctors need.

The First Cancer Diagnosis May Not Be the Final Report

This is an extremely important point for patients to understand.

You may open your patient portal and see the words:

“Invasive ductal carcinoma.”

Naturally, your first thought may be:

“What happens next?”

But your oncology team may still be waiting for some of the most important information needed to answer that question.

For invasive breast cancer, three of the most important biomarkers are:

Estrogen receptor (ER)
Progesterone receptor (PR)
HER2

These results help define the biology of the breast cancer and are critically important in determining which treatments may be effective.

In other words, knowing that someone has invasive breast cancer is important—but knowing whether that cancer is ER-positive, PR-positive, and HER2-positive or negative can dramatically change the treatment plan.

Why Do ER, PR, and HER2 Results Take Longer?

These tests require additional laboratory work beyond the initial examination of the tissue.

ER, PR, and HER2 are commonly evaluated using a technique called immunohistochemistry, or IHC.

This involves applying specialized antibodies and stains to additional sections of the tumor tissue.

The pathologist then evaluates the staining pattern.

ER and PR results typically include the percentage of tumor cells showing receptor staining and may also describe staining intensity.

HER2 IHC is generally reported as:

HER2 IHC 0: HER2-negative by traditional classification
HER2 IHC 1+: HER2-negative by traditional classification
HER2 IHC 2+: equivocal
HER2 IHC 3+: HER2-positive

A HER2 IHC result of 2+ is particularly important to understand.

It does not mean the cancer is HER2-positive.

It also does not mean the cancer is HER2-negative.

It essentially means:

“We don’t know yet.”

What Happens If HER2 Is 2+?

When HER2 testing by IHC is 2+, additional testing is required to determine whether the cancer is truly HER2-positive or HER2-negative.

This is commonly performed with an in situ hybridization test, often referred to as HER2 FISH, or fluorescence in situ hybridization.

Rather than measuring the amount of HER2 protein on the cancer cells, FISH evaluates the HER2 gene and determines whether it is amplified.

In simplified terms:

HER2 amplified / FISH positive generally means HER2-positive breast cancer.

HER2 not amplified / FISH negative generally means HER2-negative breast cancer when interpreted according to current HER2 testing criteria.

FISH is a more specialized test and may take additional time. In some settings, the specimen or slides may need to be sent to another laboratory for testing.

This means you may receive your breast cancer diagnosis first, then your ER and PR results, then your HER2 IHC result—and still not have your final HER2 status if the IHC result is 2+.

You are not necessarily waiting because something has gone wrong.

Sometimes you are simply waiting because the laboratory needs to complete the next necessary test.

Could It Really Take Three or Four Weeks to Have All the Information?

Yes.

Although many pathology laboratories complete this process considerably faster, there are circumstances in which obtaining the initial diagnosis plus all of the necessary receptor testing can take several weeks.

For example, the sequence might look like this:

First, the biopsy is processed and reviewed and an initial diagnosis is made.

Next, ER, PR, and HER2 testing by IHC is performed.

If HER2 is 0, 1+, or 3+, the HER2 status may be established from the IHC testing in the appropriate clinical context.

But if HER2 is 2+, additional ISH/FISH testing is needed.

That additional test may take longer.

When you add weekends, holidays, staffing limitations, laboratory volume, additional stains, outside testing, or a need for expert pathology review, the time from biopsy to having the major pieces of information needed for treatment planning can occasionally approach three to four weeks.

That can feel like an eternity when you are the person waiting.

Why Did My Pathology Report Appear in My Portal Before My Doctor Called Me?

This has become an increasingly common experience.

Many healthcare systems release test results electronically to patients very quickly, sometimes as soon as the result is finalized.

That means you may receive an alert on your phone, open your patient portal, and see the words “invasive carcinoma” before you have spoken with your doctor.

That can be incredibly upsetting.

It is also important not to assume that because the report appeared in your portal, your doctor has already personally reviewed it.

Physicians may be seeing patients, performing procedures, covering the hospital, taking call, or occasionally be away from the office when a result is released.

Electronic release of a result and personal review of that result by your physician are not necessarily simultaneous events.

If you receive a cancer diagnosis through your portal and have not heard from your doctor’s office, it is reasonable to contact the office. If the result arrives after hours, you can call when the office opens the next business day and request a call back to discuss the result and next steps.

You do not have to sit silently staring at your portal waiting for someone to notice.

Remember: Your First Report May Still Be Incomplete

This is worth repeating because it can prevent a great deal of confusion.

There may be a gap between:

“We found breast cancer.”

and:

“We now understand enough about the biology of this breast cancer to begin developing a treatment plan.”

That gap may include waiting for ER, PR, HER2 IHC, and potentially HER2 FISH testing.

Other information may also still be needed, depending on your situation, including breast MRI, lymph node evaluation, genetic testing, additional imaging, surgical pathology, or genomic testing such as an Oncotype DX recurrence score.

So if your doctor tells you that more information is needed before recommending treatment, that does not necessarily mean anyone is delaying your care.

Breast cancer treatment is increasingly personalized, and choosing the right treatment requires knowing what type of breast cancer you are treating.

What Can I Do While I’m Waiting?

Waiting is difficult because it can feel like you have lost control.

One way to regain some of that control is to turn fear into knowledge—and knowledge into power.

You can begin learning the basic vocabulary of your diagnosis.

What does ER-positive mean?

What does PR-positive mean?

What does HER2-positive or HER2-negative mean?

What is the difference between a lumpectomy and a mastectomy?

What type of doctors might be involved in your care?

Which questions do you want to ask at your upcoming appointments?

You do not need to become an oncologist overnight.

But understanding the fundamentals can make the conversations with your medical team much easier to follow.

And the more prepared you are for your appointments, the more productive those visits can become.

You Don’t Have to Navigate the Waiting Period Alone

The period immediately after a cancer diagnosis can be particularly difficult.

You may have enough information to know that you have breast cancer—but not enough information yet to know exactly what treatment you will need.

That uncertainty can be overwhelming.

MyFriendMD sessions can help patients navigate this early part of the cancer journey after a diagnosis has been made by their medical team.

During a session, we can provide general education about topics such as ER, PR, and HER2; help explain common breast cancer terminology; discuss the different types of physicians who may become part of your cancer team; review general concepts surrounding breast surgery; and help you organize questions for upcoming medical appointments.

The goal is not to replace your oncologist, surgeon, radiologist, pathologist, or other members of your healthcare team.

It is to help you better understand the information you have already been given so you can feel more prepared between medical appointments.

When you understand the language of breast cancer, it becomes easier to participate in conversations about your care.

The more prepared you are, the more fruitful your doctor visits can be—and ultimately, the more comfortable and empowered you may feel navigating the road ahead.

The Bottom Line

Waiting for breast biopsy results is hard.

Even when everything is moving appropriately behind the scenes, it may not feel that way when you are waiting to learn whether you have cancer.

Remember that your biopsy specimen must pass through multiple careful steps before a pathologist can make a diagnosis. And if breast cancer is identified, additional testing for ER, PR, and HER2 may be necessary before your medical team has the information needed to discuss treatment.

Sometimes the initial diagnosis comes first.

The receptors come later.

And if HER2 is 2+ by IHC, HER2 FISH testing can add another period of waiting before the final HER2 result is known.

Depending on the laboratory and complexity of testing, having all of this information can occasionally take several weeks.

Knowing why you are waiting doesn’t make the wait easy.

But understanding the process can make it a little less frightening.

Use this time to learn, organize your questions, and prepare for your upcoming appointments.

Turn fear into knowledge—and knowledge into power.

This article is for educational and supportive purposes only and is not intended to provide medical advice, diagnosis, or treatment. Individual pathology processing times and testing requirements vary. Questions about your biopsy, pathology results, or timing of your results should be discussed with your licensed healthcare team. MyFriendMD provides educational and supportive cancer coaching and does not replace care from your treating physicians or other licensed healthcare professionals.

Worried About the Cost of a Session?

We never want cost to be the reason someone faces a breast cancer diagnosis without support. If a session is not within reach for you right now, email us at info@myfriendmd.com and we will do what we can to help.

Book Now